To study how USP6 was regulated in CML, we conducted literature search and found that miR-146a-5p was downregulated in patients with IM-resistant CML and involved in signaling the presence of DNA damage and activating cell cycle checkpoint [28]. This evidence concerns the gene USP6 and chronic myelogenous leukemia, BCR-ABL1 positive.